What are the contraindications and side effect profiles of recently FDA-approved insomnia medications for individuals managing mild obstructive sleep apnea?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the contraindications and side effect profiles of recently FDA-approved insomnia medications for individuals managing mild obstructive sleep apnea?
4 real searches · 1 real-search pass
FDA prescribing information daridorexant Quviviq obstructive sleep apnea contraindications adverse reactions labelGoogle ↗
OBSERVED
FDA prescribing information lemborexant Dayvigo obstructive sleep apnea contraindications adverse reactions labelGoogle ↗
OBSERVED
FDA prescribing information suvorexant Belsomra obstructive sleep apnea contraindications adverse reactions labelGoogle ↗
OBSERVED
dual orexin receptor antagonists mild obstructive sleep apnea respiratory safety randomized trial daridorexant lemborexantGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
FDA prescribing information daridorexant Quviviq obstructive sleep apnea contraindications adverse reactions label Google ↗
FDA prescribing information lemborexant Dayvigo obstructive sleep apnea contraindications adverse reactions label Google ↗
FDA prescribing information suvorexant Belsomra obstructive sleep apnea contraindications adverse reactions label Google ↗
dual orexin receptor antagonists mild obstructive sleep apnea respiratory safety randomized trial daridorexant lemborexant Google ↗
- These highlights do not include all the information needed to use QUVIVIQ safely and effectively. See full prescribing information for QUVIVIQ. QUVIVIQ (daridorexant) tablets, for oral use, CIV Initial U.S. Approval: 2022 · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 · dailymed.awsprod.nlm.nih.gov
- label · accessdata.fda.gov
- Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea · pubmed.ncbi.nlm.nih.gov
- Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study · pubmed.ncbi.nlm.nih.gov
- A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea · pubmed.ncbi.nlm.nih.gov
- These highlights do not include all the information needed to use BELSOMRA safely and effectively. See full prescribing information for BELSOMRA. BELSOMRA® (suvorexant) tablets, for oral use, C-IV Initial U.S. Approval: 2014 · dailymed.nlm.nih.gov
- Assessment of the effect of the dual orexin receptor antagonist daridorexant on various indices of disease severity in patients with mild to moderate obstructive sleep apnea · pubmed.ncbi.nlm.nih.gov
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA prescribing information daridorexant Quviviq obstructive sleep apnea contraindications adverse reactions label OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA prescribing information lemborexant Dayvigo obstructive sleep apnea contraindications adverse reactions label OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA prescribing information suvorexant Belsomra obstructive sleep apnea contraindications adverse reactions label OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
dual orexin receptor antagonists mild obstructive sleep apnea respiratory safety randomized trial daridorexant lemborexant OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |